Green tea polyphenolic compounds and human health

Journal fur Verbraucherschutz und Lebensmittelsicherheit

Volumn 2, Issue 4, 2007, Pages 407-413

  Barbosa, D S ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

Antioxidants; Catechins; Flavonoids; Green tea; Polyphenols

Indexed keywords

EID: 38949141613     PISSN: 16615751     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00003-007-0246-z     Document Type: Article

References (35)

1. Ahmad, N. and Mukhtar, H. (1999) Green tea polyphenols and cancer: biologic mechanisms and practical implications. Nutr Rev 57:78-83.
2. Bordoni, A., Hrelia, S., Angeloni, C., Giordano, E., Guarnieri, C., Caldarera, C. M. and Biagi, P. L. (2002) Green tea protection of hypoxia/reoxygenation injury in cultured cardiac cells. J Nutr Biochem 13:103-111.
3. Bravo, L. (1998) Polyphenols: chemistry, dietary source, metabolism and nutritional significance. Nutr Rev 56:317-333.
4. Cai, Y. and Chow, H.-H. S. (2004) Pharmacokinetics and bio-availability of green tea catechins. In: Meskin, M. S., Bidlack, W. R., Davies, A. J., Lewis, D. S. and Randolph, R. K. (eds.) Phytochemicals-Mechanisms of Action. New York: CRC Press, pp. 35-49.
5. Camargo, A. E. I., Daguer, D. A. E. and Barbosa, D. S. (2006) Green tea exerts antioxidant action in vitro and its consumption increases total serum antioxidant potential in normal and dyslipidemic subjects. Nutr Res 26:626-631.
6. Cheynier, V. (2005) Polyphenols in foods are more complex than often thought. Am J Clin Nutr 81(suppl):223S-229S.
7. Silvestro, R. A. (2001) Flavonoids as antioxidants. In : Wildman R. E. C. (ed.) Handbook of Nutraceuticals and Functional Foods. New York: CRC Press, pp. 127-142.
8. Duthie, G. and Crozier, A. (2000) Plant-derived phenolic antioxidants. Curr Opin Clin Nutr Metab Care 3:447-451.
9. Galati, G., Lin, A., Sultan, A. M. and O'Brien, P. J. (2006) Cellular and in vivo hepatotoxicity caused by green tea phenolic acids and catechins. Free Radical Biol Med 40:570-580.
10. Geleijnse, J. M., Launer, L. J., van der Kuip, D. A. M., Hofman, A. and Witterman, J. C. M. (2002) Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study. Am J Clin Nutr 75:880-886.
11. Hosoda, K., Wang, M.-F., Liao, M.-L., Chuang, C.-K., Iha, M., Clevidence, B. and Yamamoto, S. (2003) Antihyperglycemic effect of oolong tea in type 2 diabetes. Diabetes Care 26:1714-1718.
12. Ioannides, C. and Yoxall, V. (2003) Antimutagenic activity of tea : role of polyphenols. Curr Opin Clin Nutr Metab Care 6:649-656.
13. Isbrucker, R. A. Edwards, J. A., Wolz, E., Davidovich, A. and Bausch, J. (2005) Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: dermal, acute and short-term toxicity studies. Food Chem Toxicol 44:636-650.
14. Iso, H., Date, C., Wakai, K., Fukui, M., Tamakoshi, A. and the JACC Study Group (2006) The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults. Ann Intern Med 144:554-562.
15. Itoh, Y., Yasui, T., Okada, A., Tozawa, K., Hayashi, Y. and Kohri, K. (2005) Preventive effects of green tea on renal stone formation and the role of oxidative stress in nephrolithiasis. J Urol 173:271-275.
16. Knekt, P., Kumpulainem, J., Järvinen, R., Rissanen, H., Heliövaara, M., Reunanen, A., Hakulinen, T. and Aromaa, A. (2002) Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 76:560-568.
17. Kroon, P. A., Clifford, M. N., Crozier, A., Day, A. J., Donovan, J. L., Manach, C. and Williamson, G. (2004) How should we assess the effects of exposure to dietary polyphenols in vitro? Am J Clin Nutr 80:15-21.
18. Kuriyama, S., Shimazu, T., Ohmori, K., Kikuchi, N., Nakaya, N., Nishino, Y., Tsubono, Y. and Tsuji, I. (2006) Green tea consumption and mortality due cardiovascular disease, cancer, and all causes in Japan - The Ohsaki Study. JAMA 296:1255-1265.
19. Lambert, J. D., Sang, S. and Yang, C. S. (2007) Possible controversy over dietary polyphenols: benefits vs risks. Chem Res Toxicol 20:583-585.
20. Ludwig, A., Lorenz, M., Grimbo, N., Steinle, F., Meiners, S., Bartsch, C., Stangl, K., Baumann, G. and Stangl, V. (2004) The tea flavonoid epigallocatechin-3-gallate reduces cytokine-induced VCAM-1 expression and monocyte adhesion to endothelial cells. Biochem Biophys Res Commun 316:659-665.
21. Manach, C., Sealbert, A., Morand, C., Rémésy, C and Jiménez, L. (2004) Polyphenols: food sources and bioavailability. Am J Clin Nutr 79:727-747.
22. Morton, L. W., Caccetta, R. A.-A., Puddey, I. B. and Croft, K. D. (2000) Chemistry and biological effects of dietary phenolic compounds : relevance to cardiovascular disease. Clin Exp Pharmacol Physiol 27:152-159.
23. Nijveldt, R. J., van Nood, E., van Hoorn, D. E. C., Boelens, P. G., van Norren, K. and van Leeuwen P. A. M. (2001) Flavonoids : a review of probable mechanisms of action and potential applications. Am J Clin Nutr 74:418-425.
24. Pan, T. Jankovic, J. and Le, W. (2003) Potential therapeutic properties of green tea polyphenols in Parkinson's disease. Drugs Aging 20:711-721.
25. Robbins, R. J., Kwilk-Uribe, C., Hammerstone, J. F. and Schmitz, H. H. (2006) Analysis of flavanols in foods : what methods are required to enable meaningful health recommendations ? J Cardiovasc Pharmacol 47(suppl 2):S110-S118.
26. Salah, N., Miller, N. J., Pagagnga, G., Tijburg, L., Bolwell, G. P. and Rice-Evans, C. (1995) Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants. Arch Biochem Biophys 322:339-346.
27. Sasaki, H., Matsumoto, M., Tanaka, T., Maeda, M. and Nakai, M. (2003) Antibacterial activity of polyphenol components in oo-long tea extract against Streptococcus mutans. Caries Res 38:2-8.
28. Song, E. K., Hur, H. and Han, M. K. (2003) Epigallocatechin gallate prevents autoimmune diabetes induced by multiple low doses of streptozotocin in mice. Arch Pharm Res. 26:559-63.
29. Tokunaga, S., White, I. R., Frost, C., Tanaka, K., Kono, S., Tokudome, S., Akamatsu, T., Moriyama, T. and Zakouji, H. (2002) Green tea consumption and serum lipids and lipoproteins in a population of healthy workers in Japan. Ann Epidemiol 12:157-165.
30. Trevisanato, S. I. and Kim, Y.-I. (2000) Tea and health. Nutr Rev 58:1-10.
31. Waltner-Law, M. E., Wang, X. L., Law, B. K., Hall, R. K., Nawano, M. and Granner, D. K. (2002) Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production. J Biol Chem 277:34933-34940.
32. Weisburger, J. H. (1999) Tea and health : the underlying mechanisms. Proc Soc Exp Biol Med 220:271-275.
33. Williams, R. J., Spencer, J. P. E. and Rice-Evans, C. (2003) Flavonoids: antioxidants or signaling molecules? Free Radic Biol Med 36:838-849.
34. Zhong, L., Goldberg, M. S., Gao, Y.-T., Hanley, J. A., Parent, M.-É. and Jin, F. (2001) A populational-based case-control study of lung cancer and green tea consumption among women living in Shanghai, China. Epidemiol 12:695-700.
35. Zingarelli, B., Sheehan, M. and Wong, H. R. (2003) Nuclear factor-KB as a therapeutic target in critical care medicine. Crit Care Med 31(suppl 1): S105-S111.